Lexaria Bioscience Stock Forum

$Lexaria Bioscience (LEXX.US)$ looks like someone w deep pockets is shorting our play....sad.

$Lexaria Bioscience (LEXX.US)$
Revolutionizing Healthcare: Lexaria Highlights Expanding Therapeutic Benefits of GLP-1 Drugs
Lexaria Bioscience provides a strategic update on the expanding therapeutic benefits of GLP-1 drugs, highlighting their growing applications beyond diabetes and weight loss. The market, dominated by semaglutide and tirzepatide, has seen remarkable growth from $300 million in 2018 to projected $30 billion in 2024. New therapeutic applications being investigated include he...

$Lexaria Bioscience (LEXX.US)$
Lexaria's GLP-1 Human Pilot Study #3 Completes Dosing as Scheduled

$Lexaria Bioscience (LEXX.US)$
ALL Study Groups using DehydraTECH Processing Outperform Rybelsus(R) in Body Weight Control in Lexaria’s 12-Week GLP-1, Diabetes Animal Study
Lexaria Bioscience Corp. (NASDAQ:LEXX) announces final 12-week results from its diabetes animal study WEIGHT-A24-1. All groups using DehydraTECH technology outperformed Rybelsus® in body weight control. DehydraTECH-liraglutide and DehydraTECH-CBD were top performers, surpassing Rybelsus® control group in body weight-loss b...

$Lexaria Bioscience (LEXX.US)$
Ethics Board Approval Granted for Lexaria's 12-Week Phase 1b DehydraTECH GLP-1 Study in Diabetes and Weight Loss

$Lexaria Bioscience (LEXX.US)$
Lexaria's Second GLP-1 Human Pilot Study Shows Zero Adverse Events in DehydraTECH-processed Rybelsus(R) Oral Capsules
Lexaria Bioscience Corp. (NASDAQ:LEXX) has announced positive results from its second GLP-1 human pilot study (GLP-1-H24-2) on DehydraTECH-processed Rybelsus® oral capsules. Key findings include:
1. Superior tolerability: None of the 9 participants taking DehydraTECH-processed Rybelsus® capsules experienced adverse events, compared...

Strong move today. If 4.11 holds watch for a push to 4.44. Here are the levels to watch today.
Larger Image: tradingview.com...
$Lexaria Bioscience (LEXX.US)$  

$Lexaria Bioscience (LEXX.US)$ Lexaria Bioscience Says Its Second Weight Loss Drug Human Study Showed No Adverse Events
MT Newswires· 1 min ago

$Lexaria Bioscience (LEXX.US)$ Reuters· 4 mins ago
Lexaria Bioscience: Dehydratech-Processed Rybelsus Evidenced Trend Toward Higher Overall Absorption Vs Rybelsus Not Processed With Dehydratech